BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 28029646)

  • 1. The role of prostate tumor overexpressed 1 in cancer progression.
    Cánovas V; Lleonart M; Morote J; Paciucci R
    Oncotarget; 2017 Feb; 8(7):12451-12471. PubMed ID: 28029646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate tumor OVerexpressed-1 (PTOV1) down-regulates HES1 and HEY1 notch targets genes and promotes prostate cancer progression.
    Alaña L; Sesé M; Cánovas V; Punyal Y; Fernández Y; Abasolo I; de Torres I; Ruiz C; Espinosa L; Bigas A; Y Cajal SR; Fernández PL; Serras F; Corominas M; Thomson TM; Paciucci R
    Mol Cancer; 2014 Mar; 13():74. PubMed ID: 24684754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel DNA-binding motif in prostate tumor overexpressed-1 (PTOV1) required for the expression of ALDH1A1 and CCNG2 in cancer cells.
    Maggio V; Cánovas V; Félix AJ; Gómez V; de Torres I; Semidey ME; Morote J; Noé V; Ciudad CJ; Paciucci R
    Cancer Lett; 2019 Jun; 452():158-167. PubMed ID: 30922918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of protein translation and c-Jun expression by prostate tumor overexpressed 1.
    Marqués N; Sesé M; Cánovas V; Valente F; Bermudo R; de Torres I; Fernández Y; Abasolo I; Fernández PL; Contreras H; Castellón E; Celià-Terrassa T; Méndez R; Ramón Y Cajal S; Thomson TM; Paciucci R
    Oncogene; 2014 Feb; 33(9):1124-34. PubMed ID: 23455324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate tumor overexpressed 1 expression in invasive urothelial carcinoma.
    Rausch S; Hennenlotter J; Scharpf M; Teepe K; Kühs U; Aufderklamm S; Bier S; Mischinger J; Gakis G; Stenzl A; Schwentner C; Todenhöfer T
    J Cancer Res Clin Oncol; 2016 May; 142(5):937-47. PubMed ID: 26746655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate Tumor Overexpressed 1 (PTOV1) Is a Novel Prognostic Marker for Nasopharyngeal Carcinoma Progression and Poor Survival Outcomes.
    Yang Q; Lin H; Wu S; Lei F; Zhu X; Song L; Hong M; Guo L
    PLoS One; 2015; 10(8):e0136448. PubMed ID: 26305455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTOV1, a novel protein overexpressed in prostate cancer containing a new class of protein homology blocks.
    Benedit P; Paciucci R; Thomson TM; Valeri M; Nadal M; Càceres C; de Torres I; Estivill X; Lozano JJ; Morote J; Reventós J
    Oncogene; 2001 Mar; 20(12):1455-64. PubMed ID: 11313889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTOV-1, a novel protein overexpressed in prostate cancer, shuttles between the cytoplasm and the nucleus and promotes entry into the S phase of the cell division cycle.
    Santamaría A; Fernández PL; Farré X; Benedit P; Reventós J; Morote J; Paciucci R; Thomson TM
    Am J Pathol; 2003 Mar; 162(3):897-905. PubMed ID: 12598323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of prostate tumor overexpressed 1 correlates with tumor progression and predicts poor prognosis in breast cancer.
    Lei F; Zhang L; Li X; Lin X; Wu S; Li F; Liu J
    BMC Cancer; 2014 Jun; 14():457. PubMed ID: 24947166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTOV1 is overexpressed in human high-grade malignant tumors.
    Fernández S; Mosquera JL; Alaña L; Sanchez-Pla A; Morote J; Ramón Y Cajal S; Reventós J; de Torres I; Paciucci R
    Virchows Arch; 2011 Mar; 458(3):323-30. PubMed ID: 21181414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTOV1 expression predicts prostate cancer in men with isolated high-grade prostatic intraepithelial neoplasia in needle biopsy.
    Morote J; Fernández S; Alaña L; Iglesias C; Planas J; Reventós J; Ramón Y Cajal S; Paciucci R; de Torres IM
    Clin Cancer Res; 2008 May; 14(9):2617-22. PubMed ID: 18451224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate tumour overexpressed-1 promotes tumourigenicity in human breast cancer via activation of Wnt/β-catenin signalling.
    Cui Y; Ma W; Lei F; Li Q; Su Y; Lin X; Lin C; Zhang X; Ye L; Wu S; Li J; Yuan Z; Song L
    J Pathol; 2016 Jul; 239(3):297-308. PubMed ID: 27060981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Estimation of the diagnostic potential of APOD, PTOV1, and EPHA4 for prostatic neoplasms].
    Allina DO; Andreeva YY; Zavalishina LE; Moskvina LV; Frank GA
    Arkh Patol; 2016; 78(5):9-14. PubMed ID: 27804940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of PTOV1 expression in cancers: A protocol for systematic review and meta-analysis.
    Yang Y; Li N; Tian G
    Medicine (Baltimore); 2021 Dec; 100(50):e28149. PubMed ID: 34918668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SGK2, 14-3-3, and HUWE1 Cooperate to Control the Localization, Stability, and Function of the Oncoprotein PTOV1.
    Pennington KL; McEwan CM; Woods J; Muir CM; Pramoda Sahankumari AG; Eastmond R; Balasooriya ER; Egbert CM; Kaur S; Heaton T; McCormack KK; Piccolo SR; Kurokawa M; Andersen JL
    Mol Cancer Res; 2022 Feb; 20(2):231-243. PubMed ID: 34654719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of PTOV1 and PIN1 exhibit common phenotypic anti-cancer effects in MDA-MB-231 cells.
    Karna SKL; Ahmad F; Lone BA; Pokharel YR
    PLoS One; 2019; 14(5):e0211658. PubMed ID: 31083670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there a role for prostate tumour overexpressed-1 in the diagnosis of HGPIN and of prostatic adenocarcinoma? A comparison with alpha-methylacyl CoA racemase.
    Scarpelli M; Mazzucchelli R; Barbisan F; Santinelli A; Lopez-Beltran A; Cheng L; Montironi R
    Int J Immunopathol Pharmacol; 2012; 25(1):67-74. PubMed ID: 22507319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The extended AT-hook is a novel RNA binding motif.
    Filarsky M; Zillner K; Araya I; Villar-Garea A; Merkl R; Längst G; Németh A
    RNA Biol; 2015; 12(8):864-76. PubMed ID: 26156556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate Tumor Overexpressed-1 (PTOV1) promotes docetaxel-resistance and survival of castration resistant prostate cancer cells.
    Cánovas V; Puñal Y; Maggio V; Redondo E; Marín M; Mellado B; Olivan M; Lleonart M; Planas J; Morote J; Paciucci R
    Oncotarget; 2017 Aug; 8(35):59165-59180. PubMed ID: 28938627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate-Specific G-Protein Coupled Receptor, an Emerging Biomarker Regulating Inflammation and Prostate Cancer Invasion.
    Rodriguez M; Siwko S; Liu M
    Curr Mol Med; 2016; 16(6):526-32. PubMed ID: 27280498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.